Yukangnuo International Health Limited (hereinafter referred to as “Yukangnuo International”), a provider of pain management solutions in Hong Kong, has submitted an application for listing on the Main Board of the Hong Kong Stock Exchange, with Jianquan Finance Limited serving as the exclusive sponsor.
According to Zhitong Finance APP, disclosures from the Hong Kong Stock Exchange on August 31 indicate that Yukangnuo International Health Limited (hereinafter referred to as “Yukangnuo International”), a provider of pain management solutions in Hong Kong, has submitted an application for listing on the Main Board of the Hong Kong Stock Exchange, with Jianquan Finance Limited serving as the exclusive sponsor.
According to the prospectus, Yukangnuo International operates under the brand “Functional Regeneration Pain & Health Group,” primarily providing a range of non-surgical, non-invasive, and non-pharmaceutical pain management therapies. The company is committed to offering customers one-stop services that integrate “pain relief, removal of stasis and acid drainage, and functional enhancement.”
Currently, the group operates three large service centers in Hong Kong, located at Times Square in Causeway Bay, Harbour City in Tsim Sha Tsui, and Central Plaza in Sha Tin. Each service center has a gross floor area of approximately 18,000 square feet.
For the fiscal year ended March 31, 2026, the number of clients served by the group increased to 11,200; the average annual spending per client also rose for three consecutive years, reaching approximately HK$60,000. In fiscal year 2026, the group achieved revenue of approximately HK$370 million.
The prospectus indicates that the group's profit margins have declined over the past two years due to growth in its client base, expansion of service center scale, and increased staffing levels to support business expansion.
Over 18 years of深耕 in pain management and health services
The group’s “Functional Regeneration Pain & Health Group” brand, under Yukangnuo International, possesses over 18 years of experience in pain management and health services. The pain management and physical function enhancement services provided by the group are primarily based on its proprietary “RDS+” therapy, which is derived from the concepts of the Traditional Chinese Medicine meridian system.
“RDS+” stands for “Relieving Pain, Dispelling Stasis and Draining Acid, and Strengthening Function.” By combining various types of energy-based therapeutic devices, it aims to improve the circulation of qi and blood as well as overall bodily functions. The group utilizes multiple energy-based therapeutic devices during treatment sessions to provide targeted pain management and physical function enhancement services to clients.
As of July 31, 2026, the group had a total of 255 employees, including Traditional Chinese Medicine practitioners, functional enhancement consultants with physiotherapy-related qualifications, nutritionists, and professionally trained therapists.
Promoting new energy-based therapeutic devices
The prospectus also mentioned that Yukangnuo International has launched a new therapeutic device based on energy principles, designed to assist in the repair of soft tissues (including muscles, ligaments, tendons, and fascia); alleviate muscle stiffness; unblock meridians to promote the circulation of qi and blood; facilitate the body's detoxification process; relax tense joints; and enhance tissue elasticity.